Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

LIFE SCIENCES RESEARCH INC (LSR) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/23/2009 8-K Quarterly results
10/21/2009 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Amendment No. 1 to Agreement and Plan of Merger by and among the Company, Parent and Merger Sub"
09/08/2009 8-K Other Events
08/18/2009 8-K Other Events
07/24/2009 8-K Form 8-K - Current report
07/09/2009 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger by and among the Company, Parent and Lion",
"Life Sciences Research, Inc. to be Acquired in Going Private Transaction for $8.50 Per Share in Cash"
06/05/2009 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
05/21/2009 8-K Form 8-K -- Current report
05/04/2009 8-K Form 8-K -- Current report
03/12/2009 8-K Form 8-K -- Current report
03/04/2009 8-K Form 8-K -- Current report
03/04/2009 8-K Other Events
Docs: "LIFE SCIENCES RESEARCH RECEIVES PROPOSAL FROM ANDREW BAKER TO ACQUIRE LSR"
03/03/2009 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "LSR ANNOUNCES FOURTH QUARTER AND FULL YEAR 2008 RESULTS"
05/21/2008 8-K Form 8-K -- Current report
03/03/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Life Sciences Research to Present at 29 th Annual Raymond James Institutional Investors Conference",
"EXH 99.2 SLIDES"
02/28/2008 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "LSR ANNOUNCES FOURTH QUARTER AND 2007 RESULTS"
08/03/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amendment to Financing Agreement",
"LSR ANNOUNCES FINANCING AMENDMENT TO REDUCE INTEREST RATE AND PRINCIPAL AMOUNT"
05/24/2007 8-K Other Events
12/22/2006 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "LSR TO COMMENCE TRADING ON NYSE ARCA"
12/20/2006 8-K/A Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
12/08/2006 8-K Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
Docs: "EMPLOYEE STOCK OPTION AGREEMENT",
"EMPLOYEE STOCK OPTION AGREEMENT",
"EMPLOYEE STOCK OPTION AGREEMENT",
"EMPLOYEE STOCK OPTION AGREEMENT"
07/05/2006 8-K Termination of a Material Definitive Agreement
06/13/2006 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Stock Option Agreement, by and between LSR and Gabor Balthazar",
"Stock Option Agreement, by and between LSR and Afonso Junqueiras",
"Stock Option Agreement, by and between LSR and Yaya Sesay"
05/22/2006 8-K Other Events
03/06/2006 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "EACH SUBSIDIARY OF PARENT LISTED AS A BORROWER ON THE SIGNATURE PAGES HERETO",
"LSR ANNOUNCES NEW $70 MILLION FINANCING"
09/08/2005 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "September 7, 2005 NYSE LISTING POSTPONED"
08/22/2005 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "LSR TO LIST ON THE NEW YORK STOCK EXCHANGE"
06/16/2005 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...
Docs: "Contract for the Sale and Purchase, between Huntingdon Life Sciences Limited and Alconbury Properties I Limited, relating to the Huntingdon, England facility",
"Contract for the Sale and Purchase, between Huntingdon Life Sciences Limited and Alconbury Properties II Limited, relating to the Eye, England facility",
"Purchase and Sale Agreement, between Huntingdon Life Sciences Inc. and Alconbury Properties III Limited relating to the East Millstone, NJ facility",
"Lease, among Alconbury Properties I Limited, ServicePharm Limited and LSR, relating to the Huntingdon, England facility",
"Lease, dated as of June 14, 2005, among Alconbury Properties II Limited, ServicePharm Limited and LSR, relating to the Eye, England facility",
"Lease Agreement, dated as of June 14, 2005, between Alconbury Properties III Limited and ServicePharm Inc., relating to the East Millstone, New Jersey facility",
"Loan Note Instrument, constituting (pound)5,500,041 ($10,000,000) Variable Rate Secured Loan Stock 2010 of Alconbury Properties I Limited",
"LSR ANNOUNCES FULL REPAYMENT OF BANK DEBT WITH PROCEEDS FROM SALE LEASEBACK AND INTERNAL CASH"
03/07/2005 8-K Other Events, Financial Statements and Exhibits
Docs: "code 39138. We suggest calling five minutes prior to the scheduled call. Life Sciences Research, Inc. is a global Contract Research Organization providing product development services to the pharmaceutical, agrochemical and biotechnology industries. LSR brings leading technology and capability to support its clients in non-clinical safety testing of new compounds in early stage development and assessment. The purpose of this work is to identify risks to humans, animals or the environment resulting from the use or manufacture of a wide range of chemicals which are essential components of LSR's clients' products. The Company's services are designed to meet the regulatory requirements of governments around the world. LSR operates research facilities in the United States (the Princeton Research Center, New Jersey) and the United Kingdom (Huntingdon and Eye, England). Information on LSR's business, recent press releases, and SEC filings can be obtained through its website at www.lsrinc.net. This announcement contains statements that may be forward-looking as defined by the USA's Private Securities Litigation Reform Act of 1995. These statements are based largely on LSR's expectations and are subject to a number of risks and uncertainties, certain of which are beyond LSR's control, as more fully described in the Company's SEC filings, including its Form 10-K for the fiscal year ended December 31, 2003. - tables to follow -"
12/02/2004 8-K Other Events
05/26/2004 8-K Other events, Financial statements and exhibits
Docs: "LSR ANNOUNCES INDICTMENTS OF ANIMAL RIGHTS EXTREMISTS"
03/22/2004 8-K Other events, Financial statements and exhibits
Docs: "LSR ANNOUNCES 2003 RESULTS"
09/11/2003 8-K Other events
04/17/2003 8-K/A Changes in registrant's certifying accountant, Financial statements and exhibits
Docs: "Exhibit 16 April 17, 2003 Securities and Exchange Commission Mail Stop 11-3 450 5th Street, N. W. Washington D.C. 20549"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy